Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of JYP0066 cream in mild-to-moderate atopic dermatitis
CTR20262679Phase 2Active
- Sponsor
- Guangzhou JOYO Pharma
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JYP0066 in atopic dermatitis (AD), sponsored by Guangzhou JOYO Pharma. Started Jul 2026; status: active.
02
Drugs
JYP0066
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20262679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262679.